Lithium Prescribing and Monitoring in Clinical Practice – A Practical Guide

Posted on May 31, 2018
Time to read: 10 minutes

In 2016, Kessing and colleagues published data on the prescription patterns of patient’s who were first diagnosed with bipolar disorder. [1]

Major changes were reported with drug prescription choices over the period from 2000 to 2011 with antiepileptic and atypical antipsychotics were prescribed substantially more than lithium, despite lithium having a substantial evidence base as a mood stabiliser with proven efficacy in acute mania, long-term prophylaxis of bipolar disorder and to a lesser extent in depressive disorders.

We covered the neuroprotective effect of lithium and a summary of its mechanism of action in a previous article.

In this article, we focus on the practical aspects of prescribing lithium in clinical practice.

References

5 (100%) 2 votes